Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-22

Clinical Trial Update: Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study) [Phase 1, Phase 2]

View source ↗

Summary

Pilot study evaluating (-)-Epicatechin for Becker Muscular Dystrophy has completed phases 1 and 2 with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Craig McDonald, MD | Conditions: Becker Muscular Dystrophy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-12-22